. Demonstration of dietinduced decoupling of fatty acid and cholesterol synthesis by combining gene expression array and 2 H 2 O quantification. Am J Physiol Endocrinol Metab 302: E209 -E217, 2012. First published November 1, 2011; doi:10.1152/ajpendo.00436.2011.-The liver is a crossroad for metabolism of lipid and carbohydrates, with acetyl-CoA serving as an important metabolic intermediate and a precursor for fatty acid and cholesterol biosynthesis pathways. A better understanding of the regulation of these pathways requires an experimental approach that provides both quantitative metabolic flux measurements and mechanistic insight. Under conditions of high carbohydrate availability, excess carbon is converted into free fatty acids and triglyceride for storage, but it is not clear how excessive carbohydrate availability affects cholesterol biosynthesis. To address this, C57BL/6J mice were fed either a low-fat, high-carbohydrate diet or a high-fat, carbohydrate-free diet. At the end of the dietary intervention, the two groups received 2 H2O to trace de novo fatty acid and cholesterol synthesis, and livers were collected for gene expression analysis. Expression of lipid and glucose metabolism genes was determined using a customdesigned pathway focused PCR-based gene expression array. The expression analysis showed downregulation of cholesterol biosynthesis genes and upregulation of fatty acid synthesis genes in mice receiving the high-carbohydrate diet compared with the carbohydratefree diet. In support of these findings, 2 H2O tracer data showed that fatty acid synthesis was increased 10-fold and cholesterol synthesis was reduced by 1.6-fold in mice fed the respective diets. In conclusion, by applying gene expression analysis and tracer methodology, we show that fatty acid and cholesterol synthesis are differentially regulated when the carbohydrate intake in mice is altered.
CONSUMPTION OF A DIET RICH IN CARBOHYDRATES AND FAT is
hypothesized to be a major causal factor in the development of obesity, type 2 diabetes, and cardiovascular diseases, collectively known as the metabolic syndrome. This condition is often characterized by increased secretion of triglyceride (TG)-rich, very low-density lipoprotein and accumulation of TG in the liver. Effectively treating this condition requires a better understanding of how dietary carbohydrates and fat regulate the metabolic pathways of the liver. Typically, the experimental approach to studying such metabolic pathways relies on microarray analysis of changes in gene expression or on flux studies using tracer methodology. Microarray data provide mechanistic insight into pathway changes but no quantification of the actual changes in metabolic flux. On the other hand, metabolic flux data on their own provide little information about underlying mechanisms of action. More often than not, only one of these experimental approaches is used by any given laboratory, probably because both methods are technically complex and require specialization. Here, we provide an example of the use of a pathway-focused, real-time, PCR-based gene expression array in combination with flux data to provide both quantification and mechanistic insight into changes in lipid metabolism pathways.
Acetyl-CoA is a precursor for both fatty acid and cholesterol biosynthesis, and it is expected that critical regulatory mechanisms are at play at this metabolic branch point. The pathways necessary for the conversion of carbohydrate to triglyceride are activated at the transcriptional level mainly through the combined action of the basic helix-loop-helix transcription factors sterol-responsive element-binding protein (SREBP)-1c and carbohydrate-responsive element-binding protein (ChREBP) (4, 27) . Both insulin and liver X receptor (LXR) signaling increase the expression of SREBP-1c, which in turn bind to sterol regulatory elements in the promoter region of lipogenic genes and activate their expression (4, 19, 20) . Key enzymes in the de novo lipogenesis pathways such as acetyl-CoA carboxylases A (Acaca) and B and (Acacb), fatty acid synthase (Fasn), and stearoyl-CoA desaturase (Scd) are all induced at the transcriptional level by SREBP-1c in the liver of mice (26) . ChREBP activity is regulated by glucose (or rather its downstream metabolites, e.g., hexose and/or ribose phosphates) at the transcriptional level and by direct activation by binding of glucose to ChREBP protein (8, 18) . ChREBP increases the expression of genes that contain a carbohydrate-responsive element in the promoter region; these include both glycolytic and lipogenic genes (8, 14) .
The cholesterol biosynthesis pathway is regulated mainly by SREBP-2. SREBP-2 is part of an intricate cellular system that responds to changes in membrane cholesterol (13) . In the event of decreased levels of free cholesterol in the endoplasmic reticulum membrane, SREBP-2 is released from the endoplasmic reticulum and subsequently cleaved in the Golgi by site 1 and site 2 proteases. This allows the DNA-binding domain of the protein to translocate to the cell nucleus, where transcription of cholesterol synthesis genes is turned on.
Despite the fact that hepatic fatty acid and cholesterol synthesis are sensitive to changes in nutritional status [e.g., feeding typically stimulates both pathways (2, 15)], it is unclear whether the presence/absence of dietary glucose has a comparable effect on these pathways. Typically, chow-fed animals are compared against fasted animals to study the effect of glucose on lipid synthesis. However, this is not simply comparing the presence/absence of glucose since there are marked differences in energy balance linked with feeding vs. fasting. In the current study, a carbohydrate-free diet is applied to induce a metabolic state that is observed typically with prolonged fasting [i.e., this diet is also referred to as a "ketogenic diet" (16, 17) ]. As mentioned, a major difference between fasting and consuming a carbohydrate-free diet centers on the fact that glucose, not energy, is limited.
Thus, the objective of the current study was to investigate the effects of a high-carbohydrate, low-fat diet vs. a carbohydrate-free, high-fat diet on fatty acid and cholesterol biosynthesis in vivo. We show that fatty acid synthesis is upregulated and cholesterol synthesis is downregulated under these dietary conditions and provide preliminary mechanistic insight to account for the observed changes.
MATERIALS AND METHODS
Chemicals and supplies. Unless noted, chemicals and reagents, including 99.8% 2 H2O, were purchased from Sigma-Aldrich (St. Louis, MO). Rodent diets were purchased from Research Diets (New Brunswick, NJ).
Biological experiments. C57BL/6J mice (11-wk-old males; Taconic Farms, Germantown, NY) were initially fed a regular rodent chow (Teklad 7012; Harlan, Indianapolis, IN) and then fed either a high-carbohydrate, low-fat (HC) diet (D12450B; kcal distribution equal to 10% fat, 70% carbohydrate, and 20% protein) or a carbohydrate-free, high-fat (CF) diet (D12369B; 90% fat, 0% carbohydrate, and 10% protein) ad libitum for 10 days. On the day of the study, food was removed from the cages at 7 AM; 3.5 h later, the mice were then given an intraperitoneal injection of 99.8% 2 H2O (20 l/g body wt), and animals were euthanized at 0, 1, 2, 3, 4, 5, and 6 h postinjection (n ϭ 2/time point). Animals were maintained in Association for Assessment and Accreditation of Laboratory Animal Care-accredited facilities at Merck Research Laboratories; all experimental procedures were approved by the Institutional Animal Care and Use Committee in conformance with the National Research Council's Guide for the Care and Use of Laboratory Animals.
RNA isolation, real-time quantitative PCR analysis, and custom metabolism gene expression array. Livers from mice on HC and CF diets from the t ϭ 0-, 1-, and 2-h time points (n ϭ 6/diet) were used for gene expression analysis. Liver fragments were collected in RNAlater (Qiagen, Valencia, CA) and stored at 4°C until processing. The tissues (ϳ20 mg) were homogenized in 600 l of RLT lysis buffer (Qiagen) containing 0.1% (vol/vol) ␤-mercaptoethanol using the Tissue Lyser (Qiagen). Total RNA was extracted from the homogenized liver tissues using Qiagen Robot, following the manufacturer's protocol. RNA quality was checked in Qiaxcel instrument (Qiagen). RNA concentration was measured in a Greiner half 96-well UV plate (Thermofisher Scientific, Waltham, MA) by a Bio-Tek plate reader (DTX880). Two micrograms of total RNA from each sample was used in a 50-l cDNA reaction by using high-capacity archive cDNA kit (Applied Biosystems, Foster City, CA). cDNA reaction was set up in Biomek FX liquid handling system.
A 384-well format custom-designed PCR array was developed in collaboration with SABiosciences-Qiagen. Genes representing the major lipid and glucose metabolism pathways as well as genes involved in apoptosis, autophagy, and inflammatory pathways were selected based on publicly available canonical pathway databases [Kyoto Encyclopedia of Genes and Genomes (KEGG), GeneGO, and Ingenuity]. A total of 361 genes and seven housekeeping genes were assayed. Eleven genes were added in duplicate to assay potential plate position effects. Mouse Genomic DNA Contamination primer control, reverse transcription control (duplicate), and positive PCR control (duplicate) were all included on the array as part of SABiosciences standard array setup. The complete array gene list is available upon request, and the array is available from SABiosciences-Qiagen, catalog no. CAPM09365. For the real-time PCR, 10 l of the PCR reaction mix was loaded into each well of the PCR array using Biomek FX liquid handling system. Real-time PCR was performed on the 7900HT PCR System (Applied Biosystems) with 2ϫ SYBR Fast PCR Master Mix (SABioscienses-Qiagen) and 2 l of cDNA for each reaction. Gene expression analysis was performed using the online RT 2 Profiler PCR Array Data Analysis tool (version 3.4). Briefly, the relative gene expression was determined using the comparative ⌬⌬C T method as follows; for each sample, ⌬CT for each gene was determined as the C T of the gene Ϫ the geometrical mean of the housekeeping genes (18S, Actb, Gapdh, Gusb, Hprt1, Ppia, and Rp113a). The average ⌬C T was determined for each gene in the HC and CF diet groups. ⌬⌬C T for each gene was determined as average ⌬CT (HC) Ϫ average ⌬C T (CF), and the fold change was determined as 2
The P values were determined by two-tailed equal-variance Student t-test, with the ⌬C T values of the CF and HC groups compared.
Path designer graphic representation. Custom graphic representations of lipid metabolic pathways were generated using Ingenuity Path Designer (Ingenuity Systems, Redwood City, CA). Genes and metabolites are represented as nodes, using various shapes that represent the functional class of the gene product. Arrows between metabolite nodes represent the flow of a metabolic process (solid line) or a translocation across a membrane (dotted line) ( Figs. 2A and 3A) . The gene nodes next to the arrows represent the gene product responsible for the metabolic process. All arrows and relationships are supported by data in the literature; some metabolic processes are simplified for illustrative purposes. The change in gene expression calculated as the log10 to the ratio of the HC gene expression relative to CF gene expression was overlayed onto the graphic representation in Ingenuity Path Designer. The intensity of the node color indicates the degree of up-(red) or downregulation (green).
2 H labeling of body water. The 2 H labeling of body water was determined by exchange with acetone (21) . Briefly, samples were centrifuged for 1 min in a microcentrifuge, and 20 l of sample (or standard) was reacted with 2 l of 10 N NaOH and 4 l of a 5% (vol/vol) solution of acetone in acetonitrile for 24 h at room temperature. Acetone was then extracted by the addition of 600 l of chloroform, followed by the addition of ϳ0.5 g of Na2SO4. Samples were vigorously mixed, and a small aliquot of the chloroform was transferred to a GC-MS vial. Acetone was analyzed using an Agilent 5973N-MSD equipped with an Agilent 6890 GC system, and a DB-17MS capillary column (30 m ϫ 0.25 mm ϫ 0.25 m) was used in all analyses. The temperature program was as follows: 60°C initial, increase by 20°C/min to 100°C, increase by 50°C/min to 220°C, and hold for 1 min. The sample was injected at a split ratio of 40:1 with a helium flow of 1 ml/min. Acetone eluted at ϳ1.5 min. The mass spectrometer was operated in the electron impact mode (70 eV). Selective ion monitoring of mass-to-charge ratios of 58 and 59 was performed using a dwell time of 10 ms/ion.
Concentration and 2 H labeling of total plasma palmitate and cholesterol labeling. Plasma samples for gas chromatography-quadrupole mass spectrometry analysis were processed in 1.5-ml Eppendorf tubes, and 50 l of plasma was spiked with 25 l of heptadecanoic acid (C17:0, internal standard, 0.5 mg/ml) and heated at 65°C for 1 h after 100 l 1 N KOH was added in 80% ethanol (3, 5) . Samples were acidified with 25 l of 6 N HCl and extracted in 125 l of chloroform, followed by vigorous vortexing for 20 s. The samples were centrifuged at 3,000 rpm for 5 min, and 100 l of chloroform (lower layer) was collected and evaporated to dryness under N2. Samples were derivatized using bis-trimethylsilyl trifluoroacetamide (BSTFA) ϩ 10% trimethylchlorosilane (TMCS), and 50 l was added to the sample and then incubated at 75°C for 1 h. Excess BSTFA-TMCS reagent was evaporated to dryness under N2, and the trimethylsilyl derivative was reconstituted in 50 l of ethyl acetate for analysis by GC-MS. Samples were analyzed by gas chromatography-quadrupole mass spectrometry, as described previously (5) .
TLC and derivatization to fatty acid methyl esters. Plasma (100 l) was extracted following a modification of the Folch method (10). Briefly, 50 l of 0.9% saline was added to each sample, followed by 200 l of methanol. Samples were vigorously vortexed to precipitate proteins, after which 400 l of chloroform containing heptadecanoyl-TG, -PC, -FFA, and -CE internal standards was added, and the samples were vortexed again. Phases were separated by centrifugation, and the lower layer was withdrawn to a new vessel. The samples were then extracted with two additional aliquots of chloroform (400 l each); the chloroform extracts from each round were combined and evaporated to dryness under N 2. The dried extracts were reconstituted in 100 l of chloroform for lipid separation by TLC.
TLC plates (20 ϫ 20 cm silica; Whatman) were scored into 1.2-cm lanes, and samples were spotted at the origin alongside a lane containing a mix of authentic lipid standards. Plates were developed in a solvent system composed of 80 parts hexane, 20 parts diethyl ether, and 1 part acetic acid. Lipid bands were visualized by spraying with a 0.1% solution of dichlorofluorescein in ethanol and illuminated with UV light. The bands corresponding to TGs and total phospholipids were scraped into glass tubes, lipid-bound fatty acids were converted to the methyl esters according to the procedure of Morrison and Smith (22) , and the methyl esters were then extracted into hexane, and an aliquot was removed for GC-MS analysis.
Calculations and statistical analysis. To quantify the contribution of lipid synthesis, one fits the data using a precursor/product labeling ratio to the general equation
where n is the number of exchangeable hydrogens (assumed to equal 22 and 25 for palmitate and cholesterol, respectively). Data were modeled as described previously (3, 5). The concentration and 2 H labeling of circulating palmitate and cholesterol were used to estimate the respective flux rates, and these calculations assume that the kinetics follow a single exponential term. Note that, although we obtained n ϭ 2 samples at each time point, all mice in a given diet group were used to model the flux rates.
Data in the text are shown as means Ϯ SD, unless stated otherwise.
RESULTS

Development and validation of lipid and glucose metabolism pathway-focused PCR array.
To assay gene changes in the liver in response to dietary, genetic, and/or pharmacological intervention, we developed a 384-well gene expression array that contains genes representing the major lipid and glucose metabolism pathways in the liver. Five-hundred thirty-nine GeneGo pathways, 183 ingenuity pathways, and 212 KEGG pathways were reviewed manually for pathways most relevant (Table 1) .
To evaluate the performance of the PCR array, twofold serial dilutions of a C57BL/6 mouse liver-derived cDNA were assayed in duplicate using the array. C T values for the 361 genes were distributed normally with a minimum, median, and maximum of 16.9, 25.6, and 33.2, respectively. The slopes of the C T value as function of the log2 of the dilution for the 361 PCR primers were close to 1 (0.98 Ϯ 0.08, n ϭ 361), demonstrating robustness of the individual PCR primers for detecting changes in gene expression over at least an eightfold range (Fig. 1) . To facilitate visualization of pathway changes based on the PCR array data, several maps of the array genes, organized based on pathways, were constructed using Ingenuity Path Designer.
Diet-induced changes in liver gene expression detected by gene expression array. In mice, feeding a high-carbohydrate diet is associated with changes in the expression of genes involved in fatty acid synthesis and oxidation and in glucose metabolism genes. To test the use of the mouse PCR array to detect changes in liver lipid metabolism pathways and to compare with flux data, mice were subjected to either a HC or CF diet for 10 days. The weights of the mice in the two groups at the end of the diet intervention were not significantly different [24.3 Ϯ 1.0 (HC) vs. 24.6 Ϯ 1.4 (CF)]. Based on a selection criteria of 1.5-fold up-or downregulation and P value Ͻ0.05 for the normalized gene expression values in the HC diet group compared with the normalized gene expression values in the CF group, 116 of the 361 genes assayed were differentially expressed as a result of the different diet conditions ( Table 2 ). As shown in Table 2 and Figs. 2A and 3A , several lipid and glucose metabolism pathways were affected by the dietary intervention. As illustrated in Fig. 2 , genes belonging to the mitochondrial ␤-oxidation of the fatty acid pathway were consistently downregulated under the HC condition compared with the CF condition (red color represents upregulated, green color represents downregulated). Both Acaca and Acacb were upregulated at the mRNA level. Malonyl-CoA synthesized by the mitochondrial outer membrane enzyme Acacb is hypothesized to inhibit the activity of carnitine palmitoyltransferase-1a, reducing the flow of fatty acids into mitochondria for ␤-oxidation (1). Thus, the downregulation of genes encoding the components of the ␤-oxidation pathway in combination with upregulation of Acacb predicts that, under the HC diet condition, fatty acid ␤-oxidation is reduced relative to the CF diet.
Fatty acid synthesis genes were consistently upregulated under the HC diet condition. Acaca, Acacb, Fasn, Scd1, and Elovl6 were all upregulated (Table 2 and Fig. 3 ). Other elongases and desaturases assayed (Elovl1, -2, -4, and -5 and fatty acid desaturase 1, -2, and -3) did not change (not shown). Most dramatic was the change in Scd1 mRNA, which was 65-fold increased relative to the CF diet group. Expression of Acly and Acss2, which synthesizes acetyl-CoA from citrate and acetate in the cytoplasm, were also upregulated, indicating a transcriptional response to provide precursor metabolites for fatty acid synthesis. Long-chain acyl-CoA synthetases are required for activation of fatty acids prior to synthesis of TG and fatty acid oxidation. Under the lipogenic metabolic response induced by the HC diet, Acsl4 and Acsl5 were upregulated, whereas Acsl1 and Acsf2 were downregulated (Table 2 and Fig. 3) . Acsl3, Acsf2, and Acsf3 did not change (not shown).
As shown in Fig. 3 , genes involved in cholesterol biosynthesis were downregulated (Hmgcs1, Hmgcr, Mvk, Mvd, Idi1, Fdft1, Cyp51a1, and Dhcr24) or showed no change in expression (Acat2, Pmvk, Mvd, and Dhcr7) under the HC diet condition. These changes in gene expression indicate that cholesterol biosynthesis is reduced in the HC group compared with the CF group. The Srebp-2 and low-density lipoprotein receptor (Ldlr) genes were also downregulated. The genes listed above are all regulated by the transcription factor SREBP-2, and the consistent reduction in these genes suggest reduced SREBP-2 activity in the HC group relative to the CF group. Bile acid synthesis rate may influence cholesterol synthesis. CYP7A1, an enzyme that catalyzes the first step of the classical bile acid synthesis pathway, was expressed approxi- Fig. 1 . Evaluation of the novel pathway-focused real-time PCR gene expression array. cDNA from wild-type mouse liver was diluted 2-fold, and threshold cycle (CT) values were determined using the novel PCR array. A: housekeeping genes. B: examples of array genes. Actb, actin-␤; Gusb, glucuronidase-␤; Hprt1, hypoxanthine-guanine phosphoribosyltransferase 1; Ppia, peptidylpropyl isomerase A; Rp113a, ribosomal protein L13a; Acaca, acetyl-CoA carboxylase A; Cpt-1b, carnitine palmitoyltransferase-1␤; Elovl6, elongase of verylong-chain fatty acid; Fasn, fatty acid synthase; Hmgcr, 3-hydroxymethylglutaryl-CoA reductase; Pklr, pyruvate kinase, liver type; Scd1, stearoyl-CoA desaturase. mately fivefold lower in the HC group compared with the CF group ( Fig. 3 and Table 2 ). Stable isotope labeling data. Stable isotope tracer studies were conducted to determine whether the changes in gene expression translated into changes in metabolic flux. As shown in Fig. 4 , steady-state labeling of plasma water was maintained over the course of the study, and this is expected since the pool of water does not undergo substantial turnover within a few hours after 2 H 2 O is administered to a mouse. However, the dietary intervention resulted in marked differences in the 2 H labeling of total plasma palmitate and cholesterol, and palmitate labeling was nearly 10-fold greater in HC-vs. CF-fed mice, yet cholesterol labeling was nearly twofold greater in CF-vs. HC-fed mice. The calculated rates of palmitate synthesis were 160 Ϯ 50 vs. 12 Ϯ 2 g·ml Ϫ1 ·h Ϫ1 in mice fed the HC vs. the CF diets (means Ϯ SE, P Ͻ 0.01), respectively. The calculated rates of cholesterol synthesis were 1.5 Ϯ 0.3 vs. 2.4 Ϯ 0.4 g·ml Ϫ1 ·h Ϫ1 in mice fed the HC vs. the CF diets (means Ϯ SE, P ϭ 0.05), respectively.
There were no major differences observed when the relative changes in 2 H labeling of fatty acids were compared within the respective lipid subclasses; i.e., palmitate and stearate were labeled to a similar degree in TGs and phospholipids, and each was more heavily labeled compared with oleate (data not shown).
DISCUSSION
The use of pathway-focused, quantitative, real-time PCRbased gene expression arrays offer a number of advantages compared with microarrays. Cost per sample is lower, many providers of PCR-based gene expression arrays offer flexibility in array setup (genes, replicates, etc.), and data analysis is fast and straightforward, not requiring specialized bioinformatics data processing. Perhaps most importantly, the entire datagenerating processes can be run in any laboratory with access to a real-time PCR instrument. In the current study, we utilized a custom-designed PCR array to determine differential gene expression in lipid and glucose metabolism pathways under HC and CF dietary conditions in mice. Furthermore, we compared the gene expression data against changes in de novo lipogenesis determined using 2 H 2 O tracer. The two methodologies led to similar conclusions with respect to the partitioning of carbon at the lipogenic branch point acetyl-CoA. Not surprisingly, the HC condition was characterized by reduced fatty acid oxidation and increased fatty acid synthesis relative to the CF (high-fat) condition. A novel finding, however, was that cholesterol synthesis genes and de novo cholesterol synthesis were reduced in HC diet-fed mice relative to CF-fed mice. On the basis of these findings, we conclude that manipulation of the dietary carbon source is sufficient to partially decouple fatty acid and cholesterol synthesis.
Under most physiological conditions, regulation of cholesterol and fatty acid synthesis are cocoordinated; however, high cholesterol feeding leads to decoupling of the cholesterol and fatty acid synthesis pathways. For example, Gould et al. (12) fed dogs increasing amounts of cholesterol and found a decrease in the rate of hepatic cholesterol synthesis with no or little effect on fatty acid synthesis. It was later shown in mice that increased flux of cholesterol to the liver via oxysterols activates the transcription factor LXR␣, which in turn increases the expression of SREBP-1c (24) . It is hypothesized that the increase in SREBP-1c mRNA compensates for the restrains imposed by cholesterol on the translocation of SREBP to Golgi for cleavage, thus maintaining fatty acid synthesis (11) . The data presented here show an alternative mechanism for uncoupling of cholesterol and fatty acid synthesis pathways in vivo induced by manipulating the carbohydrate source of the diet. Based on caloric density and cholesterol content of the two diets (trace amounts in both diets), we estimate that the cholesterol intake is ϳ46 and 52 g/day for HC and CF, respectively. Thus, Fig. 2 . Gene expression analysis of the fatty acid metabolism pathways. Expression of genes encoding transporters and enzymes involved in the oxidation of fatty acids in the mitochondria was downregulated in mice fed the high-carbohydrate (HC) diet compared with mice fed the carbohydrate-free (CF) diet, whereas mRNA for the malonyl-CoA-synthesizing enzymes Acaca and Acacb were upregulated. A: pathway map; the intensity of the node color indicates the degree of up-(red) or downregulation (green) based on the gene expression data (Table 2) . B: bar graph of same data (means Ϯ SE). Fig. 3 . Gene expression analysis of the de novo fatty acid and cholesterol biosynthesis pathways. The majority of genes involved in cholesterol biosynthesis were downregulated, whereas genes involved in fatty acid synthesis were upregulated. A: pathway map; the intensity of the node color indicates the degree of up-(red) or downregulation (green) based on the gene expression data ( Table 2) . B: bar graph of same data (means Ϯ SE).
we do not expect differences in cholesterol intake to play a major role in the observed decoupling.
Whereas determination of lipid flux rates gives precise quantitative readouts of the changes in the activity of lipid metabolism pathways, e.g., fatty acid and cholesterol synthesis, as shown here, flux rates provide little information about potential shifts in transcriptional activity driving such changes. The liver contains a number of transcription factors that depend on endogenous ligands derived from nutrients for transcriptional activity. SREBPs are tightly regulated by sterols, LXR is regulated by oxysterols (cholesterol derived), bile acids activate FXR, ChREBP is a potent sensor of glucose levels, and peroxisome proliferator-activated receptors (PPARs) are activated by fatty acids. In addition, cross-talk exists between these transcription factors, for example, via competition for cofactors, as demonstrated for LXR-retinoid X receptor-PPAR␣ (28) . By determining the expression of genes regulated by these transcription factors, it is possible to predict the activity of these and thus the metabolic state of the liver. What mechanistic insights can be derived from the gene expression data with respect to the transcriptional regulation of fatty acid and cholesterol synthesis under the dietary conditions? Looking at the pathway maps ( Figs. 2A and 3A) , three major pathways stand out: mitochondrial fatty acid oxidation, fatty acid synthesis, and cholesterol synthesis. Both SREBP-1c and ChREBP regulate fatty acid synthesis; SREBP-1c is activated either through transcriptional activation by LXR (24) or by insulin via increased LXR-mediated expression or increased proteolytic activation (6) . Since SREBP-1c mRNA was not significantly increased, LXR most likely is not involved in activation under the current conditions. In addition, LXR canonical transcription targets (e.g., lipoprotein lipase, ATPbinding cassette transporter A1, and ATP-binding cassette transporter G1) were not upregulated. The genes activated by SREBP-1c and ChREBP are overlapping; however, of the two, PKLR is regulated at the mRNA level only by ChREBP (7). PKLR expression was 4.3-fold different for HC vs. CF, suggesting ChREBP transcriptional activity as a major determinant of the difference in fatty acid synthesis. Based on these changes in gene expression, it is likely that the action of glucose and its metabolites on the activation of ChREBP and subsequent induction of fatty acid synthesis genes (Fig. 2) account for a major part of the increase in fatty acid synthesis. In addition, allosteric activation of acetyl-CoA carboxylase by citrate is likely to increase the flux of acetyl-CoA toward fatty acid and triglyceride synthesis. These are well-established mechanisms, especially in rodent models, that have presumably evolved to facilitate the storage of excess glucose in the form of fat (25) .
A novel finding in this report is the differential changes in cholesterol and fatty acid synthesis under high-carbohydrate vs. high-fat diets. This is in contrast to the experimental condition of fasting/refeeding in rodents where both fatty acid and cholesterol synthesis are generally upregulated (2, 9, 15) . Specifically, the gene expression analysis showed that genes in the cholesterol synthesis pathway were downregulated (in the order of 2-to 3-fold) in mice on a HC diet relative to CF diet (Fig. 2) , and de novo cholesterol synthesis was reduced 1.6-fold (Fig. 4) . The upregulation of genes regulating fatty acid and cholesterol synthesis in fasting/refeeding is caused at least in part by an insulin-mediated drop in Insig-2 expression. This leads to activation of both SREBP-1c and SREBP-2, with increased expression of target genes as a result (9) . This transcriptional activation, in addition to the availability of substrate and energy for lipid synthesis, results in increased lipid synthesis. The major difference between fasting/refeeding and the experimental conditions in the current study is that glucose, not energy (or insulin levels), is limited. Thus, what could account for the difference in cholesterol synthesis under these two dietary conditions? One possible mechanism constituting the relative increase cholesterol synthesis in the CF (high-fat) group is an increased need for bile acid synthesis to accommodate the increase in demand for flux of bile to the digestive system to facilitate fat absorption. An increased bile acid synthesis could result in a small decrease in hepatic free cholesterol levels, which in turn would result in increased activation of SREBP-2, cholesterol synthesis genes, and cholesterol synthesis. In support of this hypothesis, CYP7A1, a rate-limiting enzyme in bile acid synthesis, was upregulated sixfold in the CF group relative to the HC group. We cannot rule out that other factors may contribute to the difference in cholesterol synthesis, especially considering that the metabolic states of the livers under the two diet conditions are very different. For example, PPAR␣ activity was dramatically dif- 2 H labeling profile of water (A), total palmitate (B), and cholesterol (C). The 2 H-labeling of plasma water remained relatively constant over the time course of the study (and was maintained at ϳ2.5%), whereas the 2 H labeling of total palmitate and cholesterol increased. Comparable 2 H labeling was observed in plasma water, yet mice fed a HC diet displayed a greater labeling in total palmitate and a lower labeling in total plasma cholesterol compared with mice fed a CF diet. Note in C the difference in scale of the left and right axes. ferent in the two diet groups, as indicated by expression of target genes [e.g., Acadm, Acsl1, Aldh3a2, Cpt2, Crot, Ehhadh, Fabp2, Gpd1, Hmgcs2, and Vldlr (23)].
In summary, the data reported herein demonstrate an approach to study carbon flow in lipogenic pathways at the branch point of acetyl-CoA using a custom-designed PCR array in combination with pathway flux analysis and a relatively simple dietary intervention. The gene expression data in combination with lipid flux measurements provide both quantitative readouts for lipid synthesis as well as mechanistic insight into pathway regulation at the gene expression level.
